SAT0236 Maintenance and Efficacy of Abatacept Monotherapy Compared to Abatacept + Conventional Synthetic DMARD in Patients with Rheumatoid Arthritis: Data from ORA Registry

M.-E. Truchetet; N. Poursac; T. Barnetche; E. Shipley; B. Bannwarth; C. Richez; T. Schaeverbeke

doi:10.1136/annrheumdis-2014-eular.2001

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

EULAR 2014: Scientific Abstracts

Poster Presentations. Rheumatoid arthritis - other biologic treatment

SAT0236 Maintenance and Efficacy of Abatacept Monotherapy Compared to Abatacept + Conventional Synthetic DMARD in Patients with Rheumatoid Arthritis: Data from ORA Registry

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password